Company: ELV
Filing Date: 2025-12-10
Form Type: 8-K
Source: 0001156039-25-000142
Chunk: 0

Company: Elevance Health, Inc.
Filing Date: 2025-12-10
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 10, 2025, the Board of Directors (the “ Board”) of Elevance Health, Inc. (the “ Company”) elected Amy W. Schulman to serve as an independent director effective January 12, 2026, with a term expiring at the Company’s 2028 annual meeting of shareholders. The Board also appointed Ms. Schulman to its Audit and Finance Committees.

There is no arrangement or understanding between Ms. Schulman and any other person pursuant to which she was elected to the Board, and Ms. Schulman has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended. The Board has determined that Ms. Schulman qualifies as an "independent director" as defined by the NYSE's listing standards and the Company's director independence guidelines, and as an “audit committee financial expert” as defined by the Securities and Exchange Commission regulations.

Ms. Schulman will receive compensation for her services as a director in accordance with the Company’s standard compensation program for non-employee directors, which is filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.

A copy of the Company’s press release announcing Ms. Schulman's election is furnished herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.